MEG3 and neoplasm: We then integratedgene expression data from 17 published studies, representing 2,999 primarybreast tumours, and found that MEG3 had the lowest average expression andwidest range of expression in the aggressive and difficult-to-treat basalmolecular subtype (Supplementary Fig.5g).